Analysis of esophagogastric cancer patients enrolled in National Cancer Institute (NCI) Cancer Therapy Evaluation Program (CTEP)-sponsored phase I trials

被引：5
|
作者：
Bando, Hideaki
Rubinstein, Larry
Harris, Pamela Jo
Yoshino, Takayuki
Doi, Toshihiko
Ohtsu, Atsushi
Welch, Jack
Takebe, Naoko
机构：
[1] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan
[2] Div Canc Treatment & Diag, Bethesda, MD USA
[3] NCI, NIH, Bethesda, MD 20892 USA
[4] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[5] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba, Japan
[6] Canc Therapy Evaluat Program, Invest Drug Branch, Rockville, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期
关键词：
D O I：
10.1200/jco.2015.33.3_suppl.12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Access to National Cancer Institute (NCI)-designated cancer centers among Native American patients with cancer
    Li, Haoran
    Sahu, Kamal Kant
    Gebrael, Georges
    Thomas, Vinay Mathew
    Tripathi, Nishita
    Sayegh, Nicolas
    Maughan, Benjamin L.
    Agarwal, Neeraj
    Swami, Umang
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] CARDIAC EVENTS (CE) IN PATIENTS (PTS) TREATED WITH MITOXANTRONE (M) IN PHASE-II TRIALS (PH-II) SPONSORED BY THE NATIONAL-CANCER-INSTITUTE (NCI)
    FOSTER, B
    LEV, L
    BERGMANN, C
    CLAGGETTCARR, C
    MARSONI, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 168 - 168
  • [43] Evolution of multidisciplinary care: Experience of the National Cancer Institute (NCI) Community Cancer Centers Program (NCCCP)
    Friedman, Eliot Lawrence
    Morris, Paul
    Currens, Margaret
    Castro, Kathleen M.
    Clauser, Steven B.
    Das, Irene Prabhu
    Carrigan, Angela
    Rivero, Silvana
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [44] Impact of phase I trials on the outcome of cancer patients. The Institute of Cancer Research experience
    Trigo, JM
    Beale, P
    Rees, C
    Judson, I
    ANNALS OF ONCOLOGY, 1998, 9 : 127 - 127
  • [45] "MANY VIEWS ON VALUE" OF NATIONAL CANCER INSTITUTE-SPONSORED RANDOMIZED TRIALS
    Nghiem, Van
    Vaidya, Riha
    Hershman, Dawn L.
    LeBlanc, Michael
    Ramsey, Scott D.
    Blanke, Charles D.
    Unger, Joseph M.
    MEDICAL DECISION MAKING, 2020, 40 (01) : E31 - E32
  • [46] Incremental treatment costs in National Cancer Institute-sponsored clinical trials
    Goldman, DP
    Berry, SH
    McCabe, MS
    Kilgore, ML
    Potosky, AL
    Schoenbaum, ML
    Schonlau, M
    Weeks, JC
    Kaplan, R
    Escarce, JJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (22): : 2970 - 2977
  • [47] Cancer therapy evaluation program (http://ctep.info.nih.gov/)
    Fukuda, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (02) : 115 - 115
  • [48] Summary of the National Cancer Institute (NCI) State of the Science Conference on preoperative therapy in invasive breast cancer
    Gralow, J.
    EJC SUPPLEMENTS, 2008, 6 (07): : 107 - 107
  • [49] NCI mpact: National Cancer Institute molecular profiling-based assignment of cancer therapy.
    Kummar, Shivaani
    Williams, Mickey
    Lih, Chih-Jian
    Chen, Alice P.
    Rubinstein, Larry
    Antony, Ramya
    Polley, Eric
    Zhao, Yingdong
    Conley, Barbara A.
    Simon, Richard
    Doroshow, James H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [50] Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program
    Minasian, Lori M.
    Tangen, Catherine M.
    Wickerham, Lawrence
    SEMINARS IN ONCOLOGY, 2015, 42 (05) : 748 - 763
12345